It goes right into your system
Most common side effects (12mg dose, across TRIUMPH-4 and TRIUMPH-1): Nausea: 43% TRIUMPH-4 / ~38% TRIUMPH-1 (mostly during dose escalation) Diarrhea: 33% / ~28% (peaks weeks 48, improves by week 16) Dysesthesia: 20.9% (tingling sensations onset variable, long-term persistence unknown) Vomiting: 21% / ~25% (decreases after month 3) Constipation: 25% Discontinuation rates: 18.2% in TRIUMPH-4 (osteoarthritis population), 11.3% in TRIUMPH-1 (general obesity population)
TSH and free T4 levels should remain within target range for at least 68 weeks, indicating stable replacement dosing
In comparison, the pancreatic islets isolated from the GLP-1R knock-out mice secreted 2 to 4-fold less insulin after incubation with GLP-1 WT, GLP-1 QMP, or Exendin-4, similar amounts to that measured for unfused WT albumin (Fig
That said, owing to a remarkable oversight, Novos Canadian patent lapsed after the company failed to pay its maintenance fees